메뉴 건너뛰기




Volumn 27, Issue 49, 2009, Pages 6894-6904

Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B-ESAT6 fusion protein

Author keywords

M. tuberculosis; Mucosal vaccine; Salmonella vector

Indexed keywords

AG85B ESAT6 VACCINE; BCG VACCINE; CHOLERA TOXIN; HYBRID PROTEIN; LIVE VACCINE; LTK63 VACCINE; MYCOBACTERIUM VACCINE; SALMONELLOSIS VACCINE; UNCLASSIFIED DRUG;

EID: 70350782332     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.007     Document Type: Article
Times cited : (31)

References (73)
  • 2
    • 46849101214 scopus 로고    scopus 로고
    • Tuberculosis
    • cited; Available from
    • WHO. Tuberculosis. Fact Sheet No 104. 2007. [cited; Available from: http://www.who.int/mediacentre/factsheets/fs104/en/].
    • (2007) Fact Sheet , Issue.104
  • 3
    • 0028153628 scopus 로고
    • Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
    • Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271 March 2 (9) (1994) 698-702
    • (1994) JAMA , vol.271 , Issue.March 2 9 , pp. 698-702
    • Colditz, G.A.1    Brewer, T.F.2    Berkey, C.S.3    Wilson, M.E.4    Burdick, E.5    Fineberg, H.V.6
  • 4
    • 33750319222 scopus 로고    scopus 로고
    • Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity
    • Dietrich J., Andersen C., Rappuoli R., Doherty T.M., Jensen C.G., and Andersen P. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. J Immunol 177 November 1 (9) (2006) 6353-6360
    • (2006) J Immunol , vol.177 , Issue.November 1 9 , pp. 6353-6360
    • Dietrich, J.1    Andersen, C.2    Rappuoli, R.3    Doherty, T.M.4    Jensen, C.G.5    Andersen, P.6
  • 5
    • 33845989506 scopus 로고    scopus 로고
    • The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis
    • Andersen C.S., Dietrich J., Agger E.M., Lycke N.Y., Lovgren K., and Andersen P. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis. Infect Immun 75 1 (2007) 408-416
    • (2007) Infect Immun , vol.75 , Issue.1 , pp. 408-416
    • Andersen, C.S.1    Dietrich, J.2    Agger, E.M.3    Lycke, N.Y.4    Lovgren, K.5    Andersen, P.6
  • 6
    • 33749511016 scopus 로고    scopus 로고
    • Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice
    • Giri P.K., Verma I., and Khuller G.K. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice. J Infect 53 5 (2006) 350-356
    • (2006) J Infect , vol.53 , Issue.5 , pp. 350-356
    • Giri, P.K.1    Verma, I.2    Khuller, G.K.3
  • 7
    • 20044361834 scopus 로고    scopus 로고
    • Recent developments in tuberculosis vaccines
    • Haile M., and Kallenius G. Recent developments in tuberculosis vaccines. Curr Opin Infect Dis 18 3 (2005) 211-215
    • (2005) Curr Opin Infect Dis , vol.18 , Issue.3 , pp. 211-215
    • Haile, M.1    Kallenius, G.2
  • 8
    • 14244264779 scopus 로고    scopus 로고
    • Recent advances in the development of live, attenuated bacterial vectors
    • Roland K.L., Tinge S.A., Killeen K.P., and Kochi S.K. Recent advances in the development of live, attenuated bacterial vectors. Curr Opin Mol Ther 7 1 (2005) 62-72
    • (2005) Curr Opin Mol Ther , vol.7 , Issue.1 , pp. 62-72
    • Roland, K.L.1    Tinge, S.A.2    Killeen, K.P.3    Kochi, S.K.4
  • 9
    • 0036801656 scopus 로고    scopus 로고
    • Bacterial infectious disease control by vaccine development
    • Curtiss III R. Bacterial infectious disease control by vaccine development. J Clin Invest 110 8 (2002) 1061-1066
    • (2002) J Clin Invest , vol.110 , Issue.8 , pp. 1061-1066
    • Curtiss III, R.1
  • 10
    • 0019819989 scopus 로고
    • Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain
    • Formal S.B., Baron L.S., Kopecko D.J., Washington O., Powell C., and Life C.A. Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain. Infect Immun 34 3 (1981) 746-750
    • (1981) Infect Immun , vol.34 , Issue.3 , pp. 746-750
    • Formal, S.B.1    Baron, L.S.2    Kopecko, D.J.3    Washington, O.4    Powell, C.5    Life, C.A.6
  • 11
    • 0343978503 scopus 로고    scopus 로고
    • Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella
    • VanCott J.L., Staats H.F., Pascual D.W., Roberts M., Chatfield S.N., Yamamoto M., et al. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J Immunol 156 February 15 (4) (1996) 1504-1514
    • (1996) J Immunol , vol.156 , Issue.February 15 4 , pp. 1504-1514
    • VanCott, J.L.1    Staats, H.F.2    Pascual, D.W.3    Roberts, M.4    Chatfield, S.N.5    Yamamoto, M.6
  • 12
    • 0035852273 scopus 로고    scopus 로고
    • Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers
    • Bumann D., Metzger W.G., Mansouri E., Palme O., Wendland M., Hurwitz R., et al. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 20 December 12 (5-6) (2001) 845-852
    • (2001) Vaccine , vol.20 , Issue.December 12 5-6 , pp. 845-852
    • Bumann, D.1    Metzger, W.G.2    Mansouri, E.3    Palme, O.4    Wendland, M.5    Hurwitz, R.6
  • 13
    • 34247362129 scopus 로고    scopus 로고
    • Ability of SPI2 mutant of S. Typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans
    • Khan S., Chatfield S., Stratford R., Bedwell J., Bentley M., Sulsh S., et al. Ability of SPI2 mutant of S. Typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans. Vaccine 25 May 22 (21) (2007) 4175-4182
    • (2007) Vaccine , vol.25 , Issue.May 22 21 , pp. 4175-4182
    • Khan, S.1    Chatfield, S.2    Stratford, R.3    Bedwell, J.4    Bentley, M.5    Sulsh, S.6
  • 14
    • 0033964153 scopus 로고    scopus 로고
    • Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers
    • Tacket C.O., Sztein M.B., Wasserman S.S., Losonsky G., Kotloff K.L., Wyant T.L., et al. Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect Immun 68 3 (2000) 1196-1201
    • (2000) Infect Immun , vol.68 , Issue.3 , pp. 1196-1201
    • Tacket, C.O.1    Sztein, M.B.2    Wasserman, S.S.3    Losonsky, G.4    Kotloff, K.L.5    Wyant, T.L.6
  • 15
    • 28644438573 scopus 로고    scopus 로고
    • Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers
    • Kirkpatrick B.D., McKenzie R., O'Neill J.P., Larsson C.J., Bourgeois A.L., Shimko J., et al. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers. Vaccine 24 January 12 (2) (2006) 116-123
    • (2006) Vaccine , vol.24 , Issue.January 12 2 , pp. 116-123
    • Kirkpatrick, B.D.1    McKenzie, R.2    O'Neill, J.P.3    Larsson, C.J.4    Bourgeois, A.L.5    Shimko, J.6
  • 16
    • 19944374089 scopus 로고    scopus 로고
    • Optimization of Salmonella enterica serovar typhi DeltaaroC DeltassaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters
    • Stratford R., McKelvie N.D., Hughes N.J., Aldred E., Wiseman C., Curtis J., et al. Optimization of Salmonella enterica serovar typhi DeltaaroC DeltassaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters. Infect Immun 73 1 (2005) 362-368
    • (2005) Infect Immun , vol.73 , Issue.1 , pp. 362-368
    • Stratford, R.1    McKelvie, N.D.2    Hughes, N.J.3    Aldred, E.4    Wiseman, C.5    Curtis, J.6
  • 17
    • 33947231293 scopus 로고    scopus 로고
    • Oral attenuated Salmonella enterica Serovar Typhimurium vaccine expressing codon-optimized HIV Type 1 Gag enhanced intestinal immunity in mice
    • Tsunetsugu-Yokota Y., Ishige M., and Murakami M. Oral attenuated Salmonella enterica Serovar Typhimurium vaccine expressing codon-optimized HIV Type 1 Gag enhanced intestinal immunity in mice. AIDS Res Hum Retrov 23 2 (2007) 278-286
    • (2007) AIDS Res Hum Retrov , vol.23 , Issue.2 , pp. 278-286
    • Tsunetsugu-Yokota, Y.1    Ishige, M.2    Murakami, M.3
  • 18
    • 14744293582 scopus 로고    scopus 로고
    • Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli
    • Lasaro M.O., Luiz W.B., Sbrogio-Almeida M.E., and Ferreira L.C. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli. Vaccine 23 March 31 (19) (2005) 2430-2438
    • (2005) Vaccine , vol.23 , Issue.March 31 19 , pp. 2430-2438
    • Lasaro, M.O.1    Luiz, W.B.2    Sbrogio-Almeida, M.E.3    Ferreira, L.C.4
  • 19
    • 0030900746 scopus 로고    scopus 로고
    • Protection against murine listeriosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the naturally somatic antigen superoxide dismutase
    • Hess J., Dietrich G., Gentschev I., Miko D., Goebel W., and Kaufmann S.H. Protection against murine listeriosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the naturally somatic antigen superoxide dismutase. Infect Immun 65 4 (1997) 1286-1292
    • (1997) Infect Immun , vol.65 , Issue.4 , pp. 1286-1292
    • Hess, J.1    Dietrich, G.2    Gentschev, I.3    Miko, D.4    Goebel, W.5    Kaufmann, S.H.6
  • 20
    • 0032900382 scopus 로고    scopus 로고
    • Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A
    • Ward S.J., Douce G., Figueiredo D., Dougan G., and Wren B.W. Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A. Infect Immun 67 5 (1999) 2145-2152
    • (1999) Infect Immun , vol.67 , Issue.5 , pp. 2145-2152
    • Ward, S.J.1    Douce, G.2    Figueiredo, D.3    Dougan, G.4    Wren, B.W.5
  • 21
    • 0025778866 scopus 로고
    • The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis
    • Content J., de la Cuvellerie A., De Wit L., Vincent-Levy-Frebault V., Ooms J., and De Bruyn J. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis. Infect Immun 59 9 (1991) 3205-3212
    • (1991) Infect Immun , vol.59 , Issue.9 , pp. 3205-3212
    • Content, J.1    de la Cuvellerie, A.2    De Wit, L.3    Vincent-Levy-Frebault, V.4    Ooms, J.5    De Bruyn, J.6
  • 22
    • 22944433876 scopus 로고    scopus 로고
    • The success and failure of BCG-implications for a novel tuberculosis vaccine
    • Andersen P., and Doherty T.M. The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat Rev Microbiol 3 8 (2005) 656-662
    • (2005) Nat Rev Microbiol , vol.3 , Issue.8 , pp. 656-662
    • Andersen, P.1    Doherty, T.M.2
  • 23
    • 0035937258 scopus 로고    scopus 로고
    • An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase
    • Anderson D.H., Harth G., Horwitz M.A., and Eisenberg D. An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase. J Mol Biol 307 March 23 (2) (2001) 671-681
    • (2001) J Mol Biol , vol.307 , Issue.March 23 2 , pp. 671-681
    • Anderson, D.H.1    Harth, G.2    Horwitz, M.A.3    Eisenberg, D.4
  • 24
    • 0242268398 scopus 로고    scopus 로고
    • Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system
    • Stanley S.A., Raghavan S., Hwang W.W., and Cox J.S. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci USA 100 October 28 (22) (2003) 13001-13006
    • (2003) Proc Natl Acad Sci USA , vol.100 , Issue.October 28 22 , pp. 13001-13006
    • Stanley, S.A.1    Raghavan, S.2    Hwang, W.W.3    Cox, J.S.4
  • 25
    • 0033151975 scopus 로고    scopus 로고
    • HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens
    • Thole J.E., Janson A.A., Cornelisse Y., Schreuder G.M., Wieles B., Naafs B., et al. HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens. J Immunol 162 June 1 (11) (1999) 6912-6918
    • (1999) J Immunol , vol.162 , Issue.June 1 11 , pp. 6912-6918
    • Thole, J.E.1    Janson, A.A.2    Cornelisse, Y.3    Schreuder, G.M.4    Wieles, B.5    Naafs, B.6
  • 26
    • 16044372353 scopus 로고    scopus 로고
    • Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
    • Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Deck R.R., et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 2 8 (1996) 893-898
    • (1996) Nat Med , vol.2 , Issue.8 , pp. 893-898
    • Huygen, K.1    Content, J.2    Denis, O.3    Montgomery, D.L.4    Yawman, A.M.5    Deck, R.R.6
  • 27
    • 0034040571 scopus 로고    scopus 로고
    • Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen
    • Olsen A.W., Hansen P.R., Holm A., and Andersen P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur J Immunol 30 6 (2000) 1724-1732
    • (2000) Eur J Immunol , vol.30 , Issue.6 , pp. 1724-1732
    • Olsen, A.W.1    Hansen, P.R.2    Holm, A.3    Andersen, P.4
  • 29
    • 0035055282 scopus 로고    scopus 로고
    • Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
    • Olsen A.W., van Pinxteren L.A.H., Okkels L.M., Rasmussen P.B., and Andersen P. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Infect Immun 69 5 (2001) 2773-2778
    • (2001) Infect Immun , vol.69 , Issue.5 , pp. 2773-2778
    • Olsen, A.W.1    van Pinxteren, L.A.H.2    Okkels, L.M.3    Rasmussen, P.B.4    Andersen, P.5
  • 30
    • 0036263333 scopus 로고    scopus 로고
    • Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis
    • Doherty T.M., Olsen A.W., van Pinxteren L., and Andersen P. Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis. Infect Immun 70 6 (2002) 3111-3121
    • (2002) Infect Immun , vol.70 , Issue.6 , pp. 3111-3121
    • Doherty, T.M.1    Olsen, A.W.2    van Pinxteren, L.3    Andersen, P.4
  • 31
    • 4644235020 scopus 로고    scopus 로고
    • Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model
    • Olsen A.W., Williams A., Okkels L.M., Hatch G., and Andersen P. Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect Immun 72 10 (2004) 6148-6150
    • (2004) Infect Immun , vol.72 , Issue.10 , pp. 6148-6150
    • Olsen, A.W.1    Williams, A.2    Okkels, L.M.3    Hatch, G.4    Andersen, P.5
  • 32
    • 20144362100 scopus 로고    scopus 로고
    • Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6
    • Langermans J.A., Doherty T.M., Vervenne R.A., van der Laan T., Lyashchenko K., Greenwald R., et al. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6. Vaccine 23 April 15 (21) (2005) 2740-2750
    • (2005) Vaccine , vol.23 , Issue.April 15 21 , pp. 2740-2750
    • Langermans, J.A.1    Doherty, T.M.2    Vervenne, R.A.3    van der Laan, T.4    Lyashchenko, K.5    Greenwald, R.6
  • 33
    • 0028918767 scopus 로고
    • Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants
    • Douce G., Turcotte C., Cropley I., Roberts M., Pizza M., Domenghini M., et al. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci USA 92 February 28 (5) (1995) 1644-1648
    • (1995) Proc Natl Acad Sci USA , vol.92 , Issue.February 28 5 , pp. 1644-1648
    • Douce, G.1    Turcotte, C.2    Cropley, I.3    Roberts, M.4    Pizza, M.5    Domenghini, M.6
  • 34
    • 0035885007 scopus 로고    scopus 로고
    • CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen
    • Mowat A.M., Donachie A.M., Jagewall S., Schon K., Lowenadler B., Dalsgaard K., et al. CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen. J Immunol 167 September 15 (6) (2001) 3398-3405
    • (2001) J Immunol , vol.167 , Issue.September 15 6 , pp. 3398-3405
    • Mowat, A.M.1    Donachie, A.M.2    Jagewall, S.3    Schon, K.4    Lowenadler, B.5    Dalsgaard, K.6
  • 35
    • 0019407618 scopus 로고
    • Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
    • Hoiseth S.K., and Stocker B.A. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291 May 21 (5812) (1981) 238-239
    • (1981) Nature , vol.291 , Issue.May 21 5812 , pp. 238-239
    • Hoiseth, S.K.1    Stocker, B.A.2
  • 36
    • 0031931453 scopus 로고    scopus 로고
    • B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis
    • Harboe M., Malin A.S., Dockrell H.S., Wiker H.G., Ulvund G., Holm A., et al. B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect Immun 66 2 (1998) 717-723
    • (1998) Infect Immun , vol.66 , Issue.2 , pp. 717-723
    • Harboe, M.1    Malin, A.S.2    Dockrell, H.S.3    Wiker, H.G.4    Ulvund, G.5    Holm, A.6
  • 37
    • 15544371478 scopus 로고    scopus 로고
    • Rapid method for the construction of Salmonella enterica Serovar Typhimurium vaccine carrier strains
    • Husseiny M.I., and Hensel M. Rapid method for the construction of Salmonella enterica Serovar Typhimurium vaccine carrier strains. Infect Immun 73 3 (2005) 1598-1605
    • (2005) Infect Immun , vol.73 , Issue.3 , pp. 1598-1605
    • Husseiny, M.I.1    Hensel, M.2
  • 38
    • 0034612342 scopus 로고    scopus 로고
    • One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
    • Datsenko K.A., and Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97 June 6 (12) (2000) 6640-6645
    • (2000) Proc Natl Acad Sci USA , vol.97 , Issue.June 6 12 , pp. 6640-6645
    • Datsenko, K.A.1    Wanner, B.L.2
  • 40
    • 0034442696 scopus 로고    scopus 로고
    • Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin
    • Chambers M.A., Williams A., Gavier-Widen D., Whelan A., Hall G., Marsh P.D., et al. Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin. Infect Immun 68 12 (2000) 7094-7099
    • (2000) Infect Immun , vol.68 , Issue.12 , pp. 7094-7099
    • Chambers, M.A.1    Williams, A.2    Gavier-Widen, D.3    Whelan, A.4    Hall, G.5    Marsh, P.D.6
  • 41
    • 20144389346 scopus 로고    scopus 로고
    • Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis
    • Williams A., Hatch G.J., Clark S.O., Gooch K.E., Hatch K.A., Hall G.A., et al. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis. Tuberculosis (Edinburgh, Scotland) 85 January-March (1-2) (2005) 29-38
    • (2005) Tuberculosis (Edinburgh, Scotland) , vol.85 , Issue.January-March 1-2 , pp. 29-38
    • Williams, A.1    Hatch, G.J.2    Clark, S.O.3    Gooch, K.E.4    Hatch, K.A.5    Hall, G.A.6
  • 42
    • 0033823019 scopus 로고    scopus 로고
    • Survival of mycobacterial species in aerosols generated from artificial saliva
    • Lever M.S., Williams A., and Bennett A.M. Survival of mycobacterial species in aerosols generated from artificial saliva. Lett Appl Microbiol 31 3 (2000) 238-241
    • (2000) Lett Appl Microbiol , vol.31 , Issue.3 , pp. 238-241
    • Lever, M.S.1    Williams, A.2    Bennett, A.M.3
  • 43
    • 0034116071 scopus 로고    scopus 로고
    • Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers
    • Angelakopoulos H., and Hohmann E.L. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers. Infect Immun 68 4 (2000) 2135-2141
    • (2000) Infect Immun , vol.68 , Issue.4 , pp. 2135-2141
    • Angelakopoulos, H.1    Hohmann, E.L.2
  • 44
    • 0032750184 scopus 로고    scopus 로고
    • Live attenuated Salmonella: a paradigm of mucosal vaccines
    • Sirard J.C., Niedergang F., and Kraehenbuhl J.P. Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol Rev 171 (1999) 5-26
    • (1999) Immunol Rev , vol.171 , pp. 5-26
    • Sirard, J.C.1    Niedergang, F.2    Kraehenbuhl, J.P.3
  • 46
    • 0034014963 scopus 로고    scopus 로고
    • Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S. enterica var. typhimurium
    • Allen J.S., Dougan G., and Strugnell R.A. Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S. enterica var. typhimurium. FEMS Immunol Med Microbiol 27 4 (2000) 275-281
    • (2000) FEMS Immunol Med Microbiol , vol.27 , Issue.4 , pp. 275-281
    • Allen, J.S.1    Dougan, G.2    Strugnell, R.A.3
  • 47
    • 0031081681 scopus 로고    scopus 로고
    • Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles
    • Challacombe S.J., Rahman D., and O'Hagan D.T. Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles. Vaccine 15 2 (1997) 169-175
    • (1997) Vaccine , vol.15 , Issue.2 , pp. 169-175
    • Challacombe, S.J.1    Rahman, D.2    O'Hagan, D.T.3
  • 48
    • 0028385269 scopus 로고
    • Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens
    • Ruedl C., Fruhwirth M., Wick G., and Wolf H. Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens. Clin Diagn Lab Immunol 1 2 (1994) 150-154
    • (1994) Clin Diagn Lab Immunol , vol.1 , Issue.2 , pp. 150-154
    • Ruedl, C.1    Fruhwirth, M.2    Wick, G.3    Wolf, H.4
  • 49
    • 0026071140 scopus 로고
    • Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine
    • Forrest B.D., LaBrooy J.T., Robinson P., Dearlove C.E., and Shearman D.J. Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine. Infect Immun 59 3 (1991) 1206-1209
    • (1991) Infect Immun , vol.59 , Issue.3 , pp. 1206-1209
    • Forrest, B.D.1    LaBrooy, J.T.2    Robinson, P.3    Dearlove, C.E.4    Shearman, D.J.5
  • 50
    • 0034017763 scopus 로고    scopus 로고
    • Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG
    • Hess J., Grode L., Hellwig J., Conradt P., Gentschev I., Goebel W., et al. Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG. FEMS Immunol Med Microbiol 27 4 (2000) 283-289
    • (2000) FEMS Immunol Med Microbiol , vol.27 , Issue.4 , pp. 283-289
    • Hess, J.1    Grode, L.2    Hellwig, J.3    Conradt, P.4    Gentschev, I.5    Goebel, W.6
  • 51
    • 0035898950 scopus 로고    scopus 로고
    • Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA
    • Mollenkopf H.J., Groine-Triebkorn D., Andersen P., Hess J., and Kaufmann S.H.E. Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA. Vaccine 19 July 16 (28-29) (2001) 4028-4035
    • (2001) Vaccine , vol.19 , Issue.July 16 28-29 , pp. 4028-4035
    • Mollenkopf, H.J.1    Groine-Triebkorn, D.2    Andersen, P.3    Hess, J.4    Kaufmann, S.H.E.5
  • 53
    • 0036085692 scopus 로고    scopus 로고
    • Prime-boost immunization strategies for infectious diseases
    • McShane H. Prime-boost immunization strategies for infectious diseases. Curr Opin Mol Ther 4 1 (2002) 23-27
    • (2002) Curr Opin Mol Ther , vol.4 , Issue.1 , pp. 23-27
    • McShane, H.1
  • 54
    • 20444444975 scopus 로고    scopus 로고
    • Prime-boost immunisation strategies for tuberculosis
    • McShane H., and Hill A. Prime-boost immunisation strategies for tuberculosis. Microbes Infect 7 5-6 (2005) 962-967
    • (2005) Microbes Infect , vol.7 , Issue.5-6 , pp. 962-967
    • McShane, H.1    Hill, A.2
  • 55
    • 0024353079 scopus 로고
    • TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties
    • Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173
    • (1989) Annu Rev Immunol , vol.7 , pp. 145-173
    • Mosmann, T.R.1    Coffman, R.L.2
  • 56
    • 0028903154 scopus 로고
    • Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract
    • Klimpel G.R., Asuncion M., Haithcoat J., and Niesel D.W. Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract. Infect Immun 63 3 (1995) 1134-1137
    • (1995) Infect Immun , vol.63 , Issue.3 , pp. 1134-1137
    • Klimpel, G.R.1    Asuncion, M.2    Haithcoat, J.3    Niesel, D.W.4
  • 57
    • 0033826580 scopus 로고    scopus 로고
    • Is the development of a new tuberculosis vaccine possible?
    • Kaufmann S.H. Is the development of a new tuberculosis vaccine possible?. Nat Med 6 9 (2000) 955-960
    • (2000) Nat Med , vol.6 , Issue.9 , pp. 955-960
    • Kaufmann, S.H.1
  • 58
    • 0027360333 scopus 로고
    • An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
    • Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., and Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178 December 1 (6) (1993) 2249-2254
    • (1993) J Exp Med , vol.178 , Issue.December 1 6 , pp. 2249-2254
    • Flynn, J.L.1    Chan, J.2    Triebold, K.J.3    Dalton, D.K.4    Stewart, T.A.5    Bloom, B.R.6
  • 60
    • 0034981752 scopus 로고    scopus 로고
    • The role of gamma interferon in antimicrobial immunity
    • Shtrichman R., and Samuel C.E. The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol 4 3 (2001) 251-259
    • (2001) Curr Opin Microbiol , vol.4 , Issue.3 , pp. 251-259
    • Shtrichman, R.1    Samuel, C.E.2
  • 61
    • 0032213010 scopus 로고    scopus 로고
    • Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria
    • Ottenhoff T.H., Kumararatne D., and Casanova J.L. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today 19 11 (1998) 491-494
    • (1998) Immunol Today , vol.19 , Issue.11 , pp. 491-494
    • Ottenhoff, T.H.1    Kumararatne, D.2    Casanova, J.L.3
  • 62
    • 0030639088 scopus 로고    scopus 로고
    • T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection
    • Murray P.J., Wang L., Onufryk C., Tepper R.I., and Young R.A. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 158 January 1 (1) (1997) 315-321
    • (1997) J Immunol , vol.158 , Issue.January 1 1 , pp. 315-321
    • Murray, P.J.1    Wang, L.2    Onufryk, C.3    Tepper, R.I.4    Young, R.A.5
  • 63
    • 0034327167 scopus 로고    scopus 로고
    • Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues
    • van Ginkel F.W., Jackson R.J., Yuki Y., and McGhee J.R. Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues. J Immunol 165 November 1 (9) (2000) 4778-4782
    • (2000) J Immunol , vol.165 , Issue.November 1 9 , pp. 4778-4782
    • van Ginkel, F.W.1    Jackson, R.J.2    Yuki, Y.3    McGhee, J.R.4
  • 64
    • 27144456562 scopus 로고    scopus 로고
    • Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines
    • Armstrong M.E., Lavelle E.C., Loscher C.E., Lynch M.A., and Mills K.H. Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines. J Infect Dis 192 November 1 (9) (2005) 1628-1633
    • (2005) J Infect Dis , vol.192 , Issue.November 1 9 , pp. 1628-1633
    • Armstrong, M.E.1    Lavelle, E.C.2    Loscher, C.E.3    Lynch, M.A.4    Mills, K.H.5
  • 65
    • 1342268107 scopus 로고    scopus 로고
    • Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy
    • Couch R.B. Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy. N Engl J Med 350 February 26 (9) (2004) 860-861
    • (2004) N Engl J Med , vol.350 , Issue.February 26 9 , pp. 860-861
    • Couch, R.B.1
  • 66
    • 1342268100 scopus 로고    scopus 로고
    • Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland
    • Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 350 February 26 (9) (2004) 896-903
    • (2004) N Engl J Med , vol.350 , Issue.February 26 9 , pp. 896-903
    • Mutsch, M.1    Zhou, W.2    Rhodes, P.3    Bopp, M.4    Chen, R.T.5    Linder, T.6
  • 67
    • 0024346776 scopus 로고
    • Pathogenesis and immunity in murine salmonellosis
    • Hsu H.S. Pathogenesis and immunity in murine salmonellosis. Microbiol Rev 53 4 (1989) 390-409
    • (1989) Microbiol Rev , vol.53 , Issue.4 , pp. 390-409
    • Hsu, H.S.1
  • 68
    • 0015848636 scopus 로고
    • Interactions between macrophages of guinea pigs and salmonellae. 3. Bactericidal action and cytophilic antibodies of macrophages of infected guinea pigs
    • Hsu H.S., and Mayo D.R. Interactions between macrophages of guinea pigs and salmonellae. 3. Bactericidal action and cytophilic antibodies of macrophages of infected guinea pigs. Infect Immun 8 2 (1973) 165-172
    • (1973) Infect Immun , vol.8 , Issue.2 , pp. 165-172
    • Hsu, H.S.1    Mayo, D.R.2
  • 69
    • 0015324214 scopus 로고
    • Acquired resistance to and comparative virulence of Salmonella typhimurium demonstrated by cutaneous lesions in guinea pigs
    • Hsu H.S., and Piper V.M. Acquired resistance to and comparative virulence of Salmonella typhimurium demonstrated by cutaneous lesions in guinea pigs. J Reticuloendoth Soc 11 4 (1972) 343-357
    • (1972) J Reticuloendoth Soc , vol.11 , Issue.4 , pp. 343-357
    • Hsu, H.S.1    Piper, V.M.2
  • 70
    • 0014311180 scopus 로고
    • Interactions between macrophages of guinea pigs and Salmonellae. I. Fate of Salmonella typhimurium within macrophages of normal guinea pigs
    • Hsu H.S., and Radcliffe A.S. Interactions between macrophages of guinea pigs and Salmonellae. I. Fate of Salmonella typhimurium within macrophages of normal guinea pigs. J Bacteriol 96 1 (1968) 191-197
    • (1968) J Bacteriol , vol.96 , Issue.1 , pp. 191-197
    • Hsu, H.S.1    Radcliffe, A.S.2
  • 71
    • 0017717279 scopus 로고
    • Interactions between salmonellae and macrophages of guinea pigs. IV. Relationship between migration inhibition and antibacterial action of macrophages
    • Mayo D.R., Hsu H.S., and Lim F. Interactions between salmonellae and macrophages of guinea pigs. IV. Relationship between migration inhibition and antibacterial action of macrophages. Infect Immun 18 1 (1977) 52-59
    • (1977) Infect Immun , vol.18 , Issue.1 , pp. 52-59
    • Mayo, D.R.1    Hsu, H.S.2    Lim, F.3
  • 72
    • 0015955913 scopus 로고
    • Effect of kanamycin on the fate of Salmonella enteritidis within cultured macrophages of guinea pigs
    • Rhodes M.W., and Hsu H.S. Effect of kanamycin on the fate of Salmonella enteritidis within cultured macrophages of guinea pigs. J Reticuloendoth Soc 15 1 (1974) 1-12
    • (1974) J Reticuloendoth Soc , vol.15 , Issue.1 , pp. 1-12
    • Rhodes, M.W.1    Hsu, H.S.2
  • 73
    • 70350746623 scopus 로고
    • Interactions between macrophages of guinea pigs and Salmonellae. II. Phagocytosis of Salmonella typhimurium by macrophages of normal guinea pigs
    • Wells P.S., and Hsu H.S. Interactions between macrophages of guinea pigs and Salmonellae. II. Phagocytosis of Salmonella typhimurium by macrophages of normal guinea pigs. Infect Immun 2 2 (1970) 145-149
    • (1970) Infect Immun , vol.2 , Issue.2 , pp. 145-149
    • Wells, P.S.1    Hsu, H.S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.